Most of these pairs are tumor suppressor gene-oncogene pairs except for TP53 and CDKN2A, which are both TSGs, suggesting a strong need for both inactivation of a TSG and activation of an oncogene to promote cancer progression (Zhu et al., 2015). This evidence concerns the gene CDKN2A and cancer.